Global Dendritic Cell Cancer Vaccine Market Research Report 2021

Global Dendritic Cell Cancer Vaccine Market Research Report 2021

Table of Contents
1 Dendritic Cell Cancer Vaccine Market Overview
1.1 Product Overview and Scope of Dendritic Cell Cancer Vaccine
1.2 Dendritic Cell Cancer Vaccine Segment by Type
1.2.1 Global Dendritic Cell Cancer Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 CreaVax
1.2.3 Sipuleucel-T (Provenge)
1.2.4 Others
1.3 Dendritic Cell Cancer Vaccine Segment by Application
1.3.1 Dendritic Cell Cancer Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Pediatrics
1.3.3 Adults
1.4 Global Dendritic Cell Cancer Vaccine Market Size Estimates and Forecasts
1.4.1 Global Dendritic Cell Cancer Vaccine Revenue 2016-2027
1.4.2 Global Dendritic Cell Cancer Vaccine Sales 2016-2027
1.4.3 Dendritic Cell Cancer Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Dendritic Cell Cancer Vaccine Market Competition by Manufacturers
2.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Dendritic Cell Cancer Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Dendritic Cell Cancer Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Dendritic Cell Cancer Vaccine Market Competitive Situation and Trends
2.5.1 Dendritic Cell Cancer Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Dendritic Cell Cancer Vaccine Players Market Share by Revenue
2.5.3 Global Dendritic Cell Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dendritic Cell Cancer Vaccine Retrospective Market Scenario by Region
3.1 Global Dendritic Cell Cancer Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Dendritic Cell Cancer Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
3.3.1 North America Dendritic Cell Cancer Vaccine Sales by Country
3.3.2 North America Dendritic Cell Cancer Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
3.4.1 Europe Dendritic Cell Cancer Vaccine Sales by Country
3.4.2 Europe Dendritic Cell Cancer Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Dendritic Cell Cancer Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Dendritic Cell Cancer Vaccine Sales by Region
3.5.2 Asia Pacific Dendritic Cell Cancer Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
3.6.1 Latin America Dendritic Cell Cancer Vaccine Sales by Country
3.6.2 Latin America Dendritic Cell Cancer Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Dendritic Cell Cancer Vaccine Sales by Country
3.7.2 Middle East and Africa Dendritic Cell Cancer Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Dendritic Cell Cancer Vaccine Historic Market Analysis by Type
4.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Dendritic Cell Cancer Vaccine Price by Type (2016-2021)
5 Global Dendritic Cell Cancer Vaccine Historic Market Analysis by Application
5.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Dendritic Cell Cancer Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Medigene
6.1.1 Medigene Corporation Information
6.1.2 Medigene Description and Business Overview
6.1.3 Medigene Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Medigene Product Portfolio
6.1.5 Medigene Recent Developments/Updates
6.2 Activarti
6.2.1 Activarti Corporation Information
6.2.2 Activarti Description and Business Overview
6.2.3 Activarti Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Activarti Product Portfolio
6.2.5 Activarti Recent Developments/Updates
6.3 Argos Therapeutics
6.3.1 Argos Therapeutics Corporation Information
6.3.2 Argos Therapeutics Description and Business Overview
6.3.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Argos Therapeutics Product Portfolio
6.3.5 Argos Therapeutics Recent Developments/Updates
6.4 Batavia Bioservices
6.4.1 Batavia Bioservices Corporation Information
6.4.2 Batavia Bioservices Description and Business Overview
6.4.3 Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Batavia Bioservices Product Portfolio
6.4.5 Batavia Bioservices Recent Developments/Updates
6.5 Bellicum Pharmaceuticals
6.5.1 Bellicum Pharmaceuticals Corporation Information
6.5.2 Bellicum Pharmaceuticals Description and Business Overview
6.5.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bellicum Pharmaceuticals Product Portfolio
6.5.5 Bellicum Pharmaceuticals Recent Developments/Updates
6.6 Creagene
6.6.1 Creagene Corporation Information
6.6.2 Creagene Description and Business Overview
6.6.3 Creagene Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Creagene Product Portfolio
6.6.5 Creagene Recent Developments/Updates
6.7 DanDrit Biotech
6.6.1 DanDrit Biotech Corporation Information
6.6.2 DanDrit Biotech Description and Business Overview
6.6.3 DanDrit Biotech Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 DanDrit Biotech Product Portfolio
6.7.5 DanDrit Biotech Recent Developments/Updates
6.8 DCPrime
6.8.1 DCPrime Corporation Information
6.8.2 DCPrime Description and Business Overview
6.8.3 DCPrime Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 DCPrime Product Portfolio
6.8.5 DCPrime Recent Developments/Updates
6.9 Sanpower (Dendreon)
6.9.1 Sanpower (Dendreon) Corporation Information
6.9.2 Sanpower (Dendreon) Description and Business Overview
6.9.3 Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Sanpower (Dendreon) Product Portfolio
6.9.5 Sanpower (Dendreon) Recent Developments/Updates
6.10 Elios Therapeutics
6.10.1 Elios Therapeutics Corporation Information
6.10.2 Elios Therapeutics Description and Business Overview
6.10.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Elios Therapeutics Product Portfolio
6.10.5 Elios Therapeutics Recent Developments/Updates
6.11 Immunicum
6.11.1 Immunicum Corporation Information
6.11.2 Immunicum Dendritic Cell Cancer Vaccine Description and Business Overview
6.11.3 Immunicum Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Immunicum Product Portfolio
6.11.5 Immunicum Recent Developments/Updates
6.12 Kiromic
6.12.1 Kiromic Corporation Information
6.12.2 Kiromic Dendritic Cell Cancer Vaccine Description and Business Overview
6.12.3 Kiromic Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Kiromic Product Portfolio
6.12.5 Kiromic Recent Developments/Updates
6.13 Merck
6.13.1 Merck Corporation Information
6.13.2 Merck Dendritic Cell Cancer Vaccine Description and Business Overview
6.13.3 Merck Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Merck Product Portfolio
6.13.5 Merck Recent Developments/Updates
6.14 Northwest Biotherapeutics
6.14.1 Northwest Biotherapeutics Corporation Information
6.14.2 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Description and Business Overview
6.14.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Northwest Biotherapeutics Product Portfolio
6.14.5 Northwest Biotherapeutics Recent Developments/Updates
6.15 Glaxo Smith Kline
6.15.1 Glaxo Smith Kline Corporation Information
6.15.2 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Description and Business Overview
6.15.3 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Glaxo Smith Kline Product Portfolio
6.15.5 Glaxo Smith Kline Recent Developments/Updates
6.16 ImmunoCellular
6.16.1 ImmunoCellular Corporation Information
6.16.2 ImmunoCellular Dendritic Cell Cancer Vaccine Description and Business Overview
6.16.3 ImmunoCellular Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.16.4 ImmunoCellular Product Portfolio
6.16.5 ImmunoCellular Recent Developments/Updates
6.17 Tella
6.17.1 Tella Corporation Information
6.17.2 Tella Dendritic Cell Cancer Vaccine Description and Business Overview
6.17.3 Tella Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Tella Product Portfolio
6.17.5 Tella Recent Developments/Updates
6.18 Vaxil Bio
6.18.1 Vaxil Bio Corporation Information
6.18.2 Vaxil Bio Dendritic Cell Cancer Vaccine Description and Business Overview
6.18.3 Vaxil Bio Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Vaxil Bio Product Portfolio
6.18.5 Vaxil Bio Recent Developments/Updates
6.19 Medigene
6.19.1 Medigene Corporation Information
6.19.2 Medigene Dendritic Cell Cancer Vaccine Description and Business Overview
6.19.3 Medigene Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Medigene Product Portfolio
6.19.5 Medigene Recent Developments/Updates
7 Dendritic Cell Cancer Vaccine Manufacturing Cost Analysis
7.1 Dendritic Cell Cancer Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine
7.4 Dendritic Cell Cancer Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Dendritic Cell Cancer Vaccine Distributors List
8.3 Dendritic Cell Cancer Vaccine Customers
9 Dendritic Cell Cancer Vaccine Market Dynamics
9.1 Dendritic Cell Cancer Vaccine Industry Trends
9.2 Dendritic Cell Cancer Vaccine Growth Drivers
9.3 Dendritic Cell Cancer Vaccine Market Challenges
9.4 Dendritic Cell Cancer Vaccine Market Restraints
10 Global Market Forecast
10.1 Dendritic Cell Cancer Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Dendritic Cell Cancer Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Dendritic Cell Cancer Vaccine by Type (2022-2027)
10.2 Dendritic Cell Cancer Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Dendritic Cell Cancer Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Dendritic Cell Cancer Vaccine by Application (2022-2027)
10.3 Dendritic Cell Cancer Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Dendritic Cell Cancer Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Dendritic Cell Cancer Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Dendritic Cell Cancer Vaccine Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Dendritic Cell Cancer Vaccine Sales (K Doses) Comparison by Application (2021-2027)
Table 3. Global Dendritic Cell Cancer Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Dendritic Cell Cancer Vaccine Covered in This Study
Table 5. Global Dendritic Cell Cancer Vaccine Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global Dendritic Cell Cancer Vaccine Sales Share by Manufacturers (2016-2021)
Table 7. Global Dendritic Cell Cancer Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Dendritic Cell Cancer Vaccine Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Dendritic Cell Cancer Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Dendritic Cell Cancer Vaccine Product Type
Table 12. Global Dendritic Cell Cancer Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Dendritic Cell Cancer Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dendritic Cell Cancer Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Dendritic Cell Cancer Vaccine Sales by Region (2016-2021) & (K Doses)
Table 16. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global Dendritic Cell Cancer Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) & (K Doses)
Table 19. North America Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) & (K Doses)
Table 23. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Dendritic Cell Cancer Vaccine Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific Dendritic Cell Cancer Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Dendritic Cell Cancer Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global Dendritic Cell Cancer Vaccine Sales (K Doses) by Type (2016-2021)
Table 39. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global Dendritic Cell Cancer Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Dendritic Cell Cancer Vaccine Revenue Share by Type (2016-2021)
Table 42. Global Dendritic Cell Cancer Vaccine Price (USD/Dose) by Type (2016-2021)
Table 43. Global Dendritic Cell Cancer Vaccine Sales (K Doses) by Application (2016-2021)
Table 44. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global Dendritic Cell Cancer Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Dendritic Cell Cancer Vaccine Revenue Share by Application (2016-2021)
Table 47. Global Dendritic Cell Cancer Vaccine Price (USD/Dose) by Application (2016-2021)
Table 48. Medigene Corporation Information
Table 49. Medigene Description and Business Overview
Table 50. Medigene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. Medigene Dendritic Cell Cancer Vaccine Product
Table 52. Medigene Recent Developments/Updates
Table 53. Activarti Corporation Information
Table 54. Activarti Description and Business Overview
Table 55. Activarti Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. Activarti Dendritic Cell Cancer Vaccine Product
Table 57. Activarti Recent Developments/Updates
Table 58. Argos Therapeutics Corporation Information
Table 59. Argos Therapeutics Description and Business Overview
Table 60. Argos Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. Argos Therapeutics Dendritic Cell Cancer Vaccine Product
Table 62. Argos Therapeutics Recent Developments/Updates
Table 63. Batavia Bioservices Corporation Information
Table 64. Batavia Bioservices Description and Business Overview
Table 65. Batavia Bioservices Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. Batavia Bioservices Dendritic Cell Cancer Vaccine Product
Table 67. Batavia Bioservices Recent Developments/Updates
Table 68. Bellicum Pharmaceuticals Corporation Information
Table 69. Bellicum Pharmaceuticals Description and Business Overview
Table 70. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product
Table 72. Bellicum Pharmaceuticals Recent Developments/Updates
Table 73. Creagene Corporation Information
Table 74. Creagene Description and Business Overview
Table 75. Creagene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. Creagene Dendritic Cell Cancer Vaccine Product
Table 77. Creagene Recent Developments/Updates
Table 78. DanDrit Biotech Corporation Information
Table 79. DanDrit Biotech Description and Business Overview
Table 80. DanDrit Biotech Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. DanDrit Biotech Dendritic Cell Cancer Vaccine Product
Table 82. DanDrit Biotech Recent Developments/Updates
Table 83. DCPrime Corporation Information
Table 84. DCPrime Description and Business Overview
Table 85. DCPrime Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 86. DCPrime Dendritic Cell Cancer Vaccine Product
Table 87. DCPrime Recent Developments/Updates
Table 88. Sanpower (Dendreon) Corporation Information
Table 89. Sanpower (Dendreon) Description and Business Overview
Table 90. Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 91. Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Product
Table 92. Sanpower (Dendreon) Recent Developments/Updates
Table 93. Elios Therapeutics Corporation Information
Table 94. Elios Therapeutics Description and Business Overview
Table 95. Elios Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 96. Elios Therapeutics Dendritic Cell Cancer Vaccine Product
Table 97. Elios Therapeutics Recent Developments/Updates
Table 98. Immunicum Corporation Information
Table 99. Immunicum Description and Business Overview
Table 100. Immunicum Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 101. Immunicum Dendritic Cell Cancer Vaccine Product
Table 102. Immunicum Recent Developments/Updates
Table 103. Kiromic Corporation Information
Table 104. Kiromic Description and Business Overview
Table 105. Kiromic Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 106. Kiromic Dendritic Cell Cancer Vaccine Product
Table 107. Kiromic Recent Developments/Updates
Table 108. Merck Corporation Information
Table 109. Merck Description and Business Overview
Table 110. Merck Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 111. Merck Dendritic Cell Cancer Vaccine Product
Table 112. Merck Recent Developments/Updates
Table 113. Northwest Biotherapeutics Corporation Information
Table 114. Northwest Biotherapeutics Description and Business Overview
Table 115. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 116. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product
Table 117. Northwest Biotherapeutics Recent Developments/Updates
Table 118. Glaxo Smith Kline Corporation Information
Table 119. Glaxo Smith Kline Description and Business Overview
Table 120. Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 121. Glaxo Smith Kline Dendritic Cell Cancer Vaccine Product
Table 122. Glaxo Smith Kline Recent Developments/Updates
Table 123. ImmunoCellular Corporation Information
Table 124. ImmunoCellular Description and Business Overview
Table 125. ImmunoCellular Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 126. ImmunoCellular Dendritic Cell Cancer Vaccine Product
Table 127. ImmunoCellular Recent Developments/Updates
Table 128. Tella Corporation Information
Table 129. Tella Description and Business Overview
Table 130. Tella Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 131. Tella Dendritic Cell Cancer Vaccine Product
Table 132. Tella Recent Developments/Updates
Table 133. Vaxil Bio Corporation Information
Table 134. Vaxil Bio Description and Business Overview
Table 135. Vaxil Bio Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 136. Vaxil Bio Dendritic Cell Cancer Vaccine Product
Table 137. Vaxil Bio Recent Developments/Updates
Table 138. Medigene Corporation Information
Table 139. Medigene Description and Business Overview
Table 140. Medigene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 141. Medigene Dendritic Cell Cancer Vaccine Product
Table 142. Medigene Recent Developments/Updates
Table 143. Production Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. Dendritic Cell Cancer Vaccine Distributors List
Table 146. Dendritic Cell Cancer Vaccine Customers List
Table 147. Dendritic Cell Cancer Vaccine Market Trends
Table 148. Dendritic Cell Cancer Vaccine Growth Drivers
Table 149. Dendritic Cell Cancer Vaccine Market Restraints
Table 150. Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2022-2027) & (K Doses)
Table 151. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 152. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 153. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 154. Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2022-2027) & (K Doses)
Table 155. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 156. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 157. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 158. Global Dendritic Cell Cancer Vaccine Sales Forecast by Region (2022-2027) & (K Doses)
Table 159. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 160. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 161. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dendritic Cell Cancer Vaccine
Figure 2. Global Dendritic Cell Cancer Vaccine Market Share by Type in 2020 & 2027
Figure 3. CreaVax Product Picture
Figure 4. Sipuleucel-T (Provenge) Product Picture
Figure 5. Others Product Picture
Figure 6. Global Dendritic Cell Cancer Vaccine Market Share by Application in 2020 & 2027
Figure 7. Pediatrics
Figure 8. Adults
Figure 9. Global Dendritic Cell Cancer Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Dendritic Cell Cancer Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global Dendritic Cell Cancer Vaccine Sales 2016-2027 (K Doses)
Figure 12. Global Dendritic Cell Cancer Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Dendritic Cell Cancer Vaccine Sales Share by Manufacturers in 2020
Figure 14. Global Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Dendritic Cell Cancer Vaccine Players: Market Share by Revenue in 2020
Figure 16. Dendritic Cell Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region (2016-2021)
Figure 18. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region in 2020
Figure 19. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2016-2021)
Figure 20. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region in 2020
Figure 21. U.S. Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Dendritic Cell Cancer Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Dendritic Cell Cancer Vaccine by Type (2016-2021)
Figure 46. Sales Market Share of Dendritic Cell Cancer Vaccine by Application (2016-2021)
Figure 47. Sales Market Share of Dendritic Cell Cancer Vaccine by Application in 2020
Figure 48. Revenue Share of Dendritic Cell Cancer Vaccine by Application (2016-2021)
Figure 49. Revenue Share of Dendritic Cell Cancer Vaccine by Application in 2020
Figure 50. Manufacturing Cost Structure of Dendritic Cell Cancer Vaccine
Figure 51. Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine
Figure 52. Dendritic Cell Cancer Vaccine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global BCG Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global BCG Vaccine market size was valued at US$ 365.6 million in 2023. With growing demand in downstream market, the BCG Vaccine is forecast to a readjusted size of US$ 542.8 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global BCG Vaccine market. BCG Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Peptide Cancer Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Peptide Cancer Vaccine market size was valued at US$ 535 million in 2023. With growing demand in downstream market, the Peptide Cancer Vaccine is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 20.5% during review period. The research report highlights the growth potential of the global Peptide Cancer Vaccine market. Peptide Cancer Vaccine are expected to show stable growth in the future market. How......

Global Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Vaccine market: According to our latest research, the global Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Cancer Vaccine market was estimated at USD 7198.2 million, and it's anticipated to reach USD 33936.62 million in 2028, with a CAGR of 29.49% during the forecast years. A cancer vaccine is a type of immunotherapy that boost the body's natural defenses by stimulating the immune system to recognize and cur......

Global Lung Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Lung Cancer Vaccines market: According to our latest research, the global Lung Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Lung Cancer Vaccines market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Lung Cancer Vaccines,A cancer vaccine for lung cance This report covers a research time span from 2018 to 2028, and ......

Global Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 105

Market Overview of Global Cancer Vaccines market: According to our latest research, the global Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Cancer Vaccines market was estimated at USD 5773.14 million, and it's anticipated to reach USD 15406.41 million in 2028, with a CAGR of 17.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Vacci......

Global Dendritic Cell Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 110

Market Overview of Global Dendritic Cell Cancer Vaccine market: According to our latest research, the global Dendritic Cell Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Dendritic Cell Cancer Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Dendritic cells (DC) are one of the major antigen presenting cells found in lymphoid organs. The main fu......

Global BCG Vaccine Market Research Report 2023, Forecast to 2028

Published: 14-Nov-2023        Price: US 2680 Onwards        Pages: 135

BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......

Global BCG Vaccine Professional Survey Report 2023, Forecast to 2028

Published: 14-Nov-2023        Price: US 3280 Onwards        Pages: 105

BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......

Infectious Vaccine Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300

Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious vaccine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of infectious vaccine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter infectious vaccine deals. These deals tend to be multicomponent, starting with......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs